Provided by Tiger Trade Technology Pte. Ltd.

Geron

1.34
-0.0600-4.29%
Post-market: 1.34-0.0050-0.37%19:49 EST
Volume:5.50M
Turnover:7.45M
Market Cap:855.40M
PE:-11.15
High:1.43
Open:1.40
Low:1.33
Close:1.40
52wk High:3.99
52wk Low:1.04
Shares:638.36M
Float Shares:534.08M
Volume Ratio:0.50
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1201
EPS(LYR):-0.2702
ROE:-29.57%
ROA:-7.79%
PB:3.44
PE(LYR):-4.96

Loading ...

Stock Track | Geron (GERN) Surges 9.17% in Pre-market Following Positive Analyst Outlook Despite Mixed Q3 Results

Stock Track
·
Nov 06

Stock Track | Geron (GERN) Plunges 5.50% After Mixed Q3 Earnings Report

Stock Track
·
Nov 06

Stock Track | Geron Plunges 5.50% Following Mixed Q3 Earnings Report and Missed Revenue Target

Stock Track
·
Nov 06

Stock Track | Geron Soars 5.50% Despite Mixed Q3 Results as Analysts Maintain Positive Outlook

Stock Track
·
Nov 06

Stock Track | Geron Soars 5.50% After Q3 Earnings and Maintained Buy Ratings

Stock Track
·
Nov 06

Geron Corporation’s Earnings Call: Mixed Sentiments and Future Prospects

TIPRANKS
·
Nov 06

Buy Rating Maintained for Geron Despite Rytelo Sales Dip, Strong Financial Position Supports Strategic Shift

TIPRANKS
·
Nov 06

Geron Is Maintained at Buy by Needham

Dow Jones
·
Nov 06

Strategic Initiatives and Market Expansion Drive Buy Rating for Geron

TIPRANKS
·
Nov 06

Stock Track | Geron Plummets 5.22% Pre-market After Q3 Revenue Miss Despite In-Line EPS

Stock Track
·
Nov 05

Stock Track | Geron Soars 8.70% Pre-Market on Strong Q3 Results and Improved 2025 Outlook

Stock Track
·
Nov 05

Geron reports Q3 EPS (3c), consensus (4c)

TIPRANKS
·
Nov 05

Stock Track | Geron Plunges 5.22% Pre-market Following Q3 Sales Miss

Stock Track
·
Nov 05

Geron Expects 2025 Operating Expenses Will Be Between $250M And $260M vs. Approximately $270M-$285M Prior

Benzinga
·
Nov 05

Geron Q3 EPS $(0.03), Inline, Sales $47.227M Miss $52.881M Estimate

Benzinga
·
Nov 05

Hematology drug developer Geron Q3 narrows net loss narrows, driven by RYTELO sales

Reuters
·
Nov 05

BRIEF-Geron Q3 EPS USD -0.03

Reuters
·
Nov 05

Geron Corp 2025 Outlook Expects Total Operating Expenses Will Be Between $250 Mln and $260 Mln

THOMSON REUTERS
·
Nov 05

Geron Corporation CEO to Present at Stifel Healthcare Conference

Reuters
·
Nov 04

Geron Highlights New RYTELO Clinical Data in Myeloid Malignancies at ASH 2025

Reuters
·
Nov 03